Moeller F Gerard, Schmitz Joy M, Herin David, Kjome Kimberly L
Department of Psychiatry and Behavioral Sciences, University of Texas Health Science Center at Houston, 1300 Moursund, Houston, TX 77030, USA.
Curr Psychiatry Rep. 2008 Oct;10(5):385-91. doi: 10.1007/s11920-008-0062-x.
The concept of using stimulants to treat cocaine and methamphetamine dependence is largely based on the "replacement" therapy model that has shown efficacy for treating nicotine and opiate dependence. Although results have been mixed, some evidence supports using stimulant medication to reduce cocaine use. There are not enough data to date to determine the efficacy of stimulants for methamphetamine dependence. Drawbacks of stimulants as treatments include the potential for abuse of the treatment, which necessitates careful screening and monitoring of patients. Possible reasons for efficacy of stimulants include enhancement of monoamine function dysregulated by chronic cocaine or methamphetamine use. Newer medications that enhance dopamine function but lack the abuse potential of older stimulants are being studied. It is hoped that these medications will provide safe, effective treatment for cocaine and methamphetamine dependence, but more research on this topic is needed.
使用兴奋剂治疗可卡因和甲基苯丙胺依赖的概念主要基于“替代”疗法模型,该模型已显示出对治疗尼古丁和阿片类药物依赖有效。尽管结果不一,但一些证据支持使用兴奋剂药物来减少可卡因的使用。迄今为止,尚无足够数据确定兴奋剂对甲基苯丙胺依赖的疗效。兴奋剂作为治疗方法的缺点包括存在治疗被滥用的可能性,这就需要对患者进行仔细筛查和监测。兴奋剂产生疗效的可能原因包括增强因长期使用可卡因或甲基苯丙胺而失调的单胺功能。正在研究能增强多巴胺功能但没有老式兴奋剂滥用潜力的新型药物。希望这些药物能为可卡因和甲基苯丙胺依赖提供安全、有效的治疗方法,但还需要对此主题进行更多研究。